Innovation in immunotherapy
- PMID: 19317800
- DOI: 10.1111/j.1365-2222.2009.03232.x
Innovation in immunotherapy
Comment on
-
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.Clin Exp Allergy. 2009 Apr;39(4):562-70. doi: 10.1111/j.1365-2222.2008.03191.x. Epub 2009 Feb 16. Clin Exp Allergy. 2009. PMID: 19226280 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
